Aims: This study aimed to evaluate the perinatal outcomes of patients who underwent cervical cerclage and to investigate the relationship between these outcomes and systemic inflammatory indices.
Methods: A retrospective study was conducted at Ankara Etlik City Hospital between November 2022 and November 2023. Patients were divided into three groups based on the indication for cerclage: history-indicated cerclage (H-IC), ultrasound-indicated cerclage (U-IC) and physical examination-indicated cerclage (PE-IC). The systemic inflammatory markers neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), Systemic Immune-Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), pan-immune inflammation value (PIV) and multi-inflammation indices (MII), were measured. The perinatal outcomes, including gestational age at delivery, birth weight and APGAR Scores, were compared among the groups.
Results: Seventy patients were included in the study. The rate of preterm birth was highest in the PE-IC group (61.1%), followed by the U-IC group (40.9%) and the H-IC group (36.7%). Birth weight, 1- and 5-minute APGAR Scores were significantly lower in the PE-IC group, and neonatal intensive care unit admission rates were significantly higher in the PE-IC group. Inflammatory markers NLR, SII and PIV were significantly higher in the U-IC group compared to the H-IC group. However, no significant differences were observed between the U-IC and PE-IC groups in terms of these markers.
Conclusion: Patients who underwent PE-IC had poorer perinatal outcomes compared to those who underwent H-IC or U-IC. The systemic inflammatory indices NLR, SII and PIV may serve as useful markers for predicting pregnancy outcomes and guiding early interventions in patients at risk of preterm birth. Further large-scale prospective studies are needed to validate these findings.
The Ankara Etlik City Hospital’s Ethics Committee gave its permission to the study protocol (approval number: AESH-EK1-2023-473). The Declaration of Helsinki’s guidelines were followed in the conduct of this study.
Amaç: Bu çalışmada servikal serklaj uygulanan hastaların perinatal sonuçlarının ve bu sonuçların sistemik inflamasyon indeksleri ile ilişkisinin değerlendirilmesi amaçlanmıştır.
Gereç ve Yöntem: Kasım 2022 ile Kasım 2023 tarihleri arasında Ankara Etlik Şehir Hastanesi'nde retrospektif bir çalışma yürütülmüştür. Hastalar serklaj endikasyonuna göre üç gruba ayrılmıştır: öykü endikasyonlu serklaj (H-IC), ultrason endikasyonlu serklaj (U-IC) ve fizik muayene endikasyonlu serklaj (PE-IC). Sistemik inflamasyon belirteçleri olan nötrofil-lenfosit oranı (NLR), trombosit-lenfosit oranı (PLR), sistemik immün-inflamasyon indeksi (SII), sistemik inflamasyon yanıt indeksi (SIRI), pan-immün inflamasyon değeri (PIV) ve multibl inflamasyon indeksleri (MII) ölçüldü. Doğumdaki gebelik yaşı, doğum ağırlığı ve APGAR skorları dahil olmak üzere perinatal sonuçlar gruplar arasında karşılaştırıldı.
Sonuçlar: Çalışmaya yetmiş hasta dahil edildi. Preterm doğum oranı PE-IC grubunda en yüksekti (%61,1), bunu U-IC grubu (%40,9) ve H-IC grubu (%36,7) izledi. Doğum ağırlığı, 1 ve 5 dakika APGAR skorları PE-IC grubunda önemli ölçüde daha düşüktü ve yenidoğan yoğun bakım ünitesine yatış oranları PE-IC grubunda önemli ölçüde daha yüksekti. İnflamatuar belirteçler NLR, SII ve PIV, U-IC grubunda H-IC grubuna kıyasla önemli ölçüde daha yüksekti. Ancak, U-IC ve PE-IC grupları arasında bu belirteçler açısından önemli bir fark gözlenmedi.
Sonuç: Fiziksel muayene ile endike serklaj uygulanan hastaların, öykü veya ultrason ile endike serklaj uygulanan hastalara kıyasla daha kötü perinatal sonuçları vardı. Sistemik inflamatuar indeksler NLR, SII ve PIV, gebelik sonuçlarını tahmin etmek ve erken doğum riski taşıyan hastalarda erken müdahaleleri yönlendirmek için yararlı belirteçler olarak hizmet edebilir. Bu bulguları doğrulamak için daha fazla büyük ölçekli prospektif çalışmaya ihtiyaç vardır.
Primary Language | English |
---|---|
Subjects | Obstetrics and Gynaecology |
Journal Section | Original Article |
Authors | |
Publication Date | January 12, 2025 |
Submission Date | October 7, 2024 |
Acceptance Date | November 26, 2024 |
Published in Issue | Year 2025 Volume: 8 Issue: 1 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.